# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Samuel Johnson (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN008-SYN-TD
- Date: 1765-04-06
- Fictional facility: St. Posthumous Health Center
- Fictional author: Catriona Bell, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Subjective

The patient participates in this fictional visit for new patient visit for severe recurrent depression and lifelong tics: depression work-up, sertraline and psychotherapy, safety assessment, and a request for neurology consultation. **S**

## Objective

Hemoglobin: 14.6 g/dL; Sodium: 140 mmol/L; Potassium: 4.3 mmol/L; Creatinine: 0.98 mg/dL; eGFR: 91 mL/min/1.73 m²; Glucose: 94 mg/dL; TSH: 2.1 mIU/L; Vitamin B12: 412 pg/mL; ALT: 24 U/L; PHQ-9: 21; GAD-7: 12; MDQ: 3; AUDIT-C: 0. All results are synthetic.

BP 128/80 mmHg; pulse 84 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 97% on room air; weight 98 kg; BMI 29.3 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Major depressive disorder, recurrent, severe, without psychotic features: low mood, loss of interest, poor sleep, guilt, and withdrawal from company for about three months on a background of depression that never fully lifted after a severe episode last year; first episode at about twenty; synthetic modern episode linked to his documented melancholy; Motor and vocal tics since childhood, with ritual counting and stepping behaviors, never formally diagnosed; neurology evaluation requested; Blindness of the left eye since early childhood after scrofula (tuberculous cervical lymphadenitis), with old scars of the neck and face; right eye myopic, corrected to normal; synthetic modern coding linked to his documented loss of sight in one eye. Strengths and supports remain part of the care plan. **S**

## Medication changes

- Started: Sertraline 50 mg oral tablet, one tablet by mouth once daily **S**

## Plan

- Sertraline started at 50 mg daily with a two-week tolerability check, and the dose adjusted by the PHQ-9. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Weekly cognitive behavioral therapy for depression, with behavioral activation and work on self-reproach. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- PHQ-9 at every visit, structured safety assessment with a written safety plan and the 988 Suicide & Crisis Lifeline, safety review at every visit, and a nurse phone check one week after starting. Guideline: Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Neurology consultation to confirm the tic disorder, exclude other movement disorders, assess obsessive-compulsive symptoms, and advise on treatment. Guideline: Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders (Pringsheim T, et al. Neurology 2019;92(19):896-906) (2019) **S**
